StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Sun Pharmaceutical Industries Limited
NSE:SUNPHARMA.NS
Sector
Location
Market Cap
USD 47.15 B
Share Price
USD 19.65
Avg Daily Volume
2,615,631
Change (1 day)
-0.67%
Change (1 year)
3.20%
Change (YTD)
-10.82%
Sun Pharmaceutical Industries Limited EBITDA Margin for the year ending March 31, 2025: 28.69%
Sun Pharmaceutical Industries Limited EBITDA Margin is 28.69% for the year ending March 31, 2025, a -0.96% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
Sun Pharmaceutical Industries Limited EBITDA Margin for the year ending March 31, 2024 was 28.97%, a 3.75% change year over year.
-
Sun Pharmaceutical Industries Limited EBITDA Margin for the year ending March 31, 2023 was 27.92%, a 60.16% change year over year.
-
Sun Pharmaceutical Industries Limited EBITDA Margin for the year ending March 31, 2022 was 17.44%, a 15.59% change year over year.
-
Sun Pharmaceutical Industries Limited EBITDA Margin for the year ending March 31, 2021 was 15.08%, a -33.33% change year over year.
Competitors
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
Johnson & Johnson
USD 163.70
JNJ
+0.72
0.44%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
McKesson Corporation
USD 709.80
MCK
-0.48
-0.07%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Elevance Health Inc.
USD 277.09
ELV
-25.36
-8.38%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%
Cencora, Inc.
USD 292.87
COR
-1.51
-0.51%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.18
600276.SS
+0.14
1.80%
Lonza Group AG
USD 710.43
LONN.SW
+2.77
0.39%
Takeda Pharmaceutical Company Limited
USD 29.16
4502.T
-0.53
-1.77%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|
Competitors
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
Johnson & Johnson
USD 163.70
JNJ
+0.72
0.44%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Bristol-Myers Squibb Company
USD 47.36
BMY
-0.70
-1.46%
McKesson Corporation
USD 709.80
MCK
-0.48
-0.07%
Chugai Pharmaceutical Co., Ltd.
USD 47.05
4519.T
+0.49
1.05%
GSK plc
USD 18.07
GSK.L
-0.88
-4.65%
Elevance Health Inc.
USD 277.09
ELV
-25.36
-8.38%
Regeneron Pharmaceuticals, Inc.
USD 542.52
REGN
-7.48
-1.36%
Cencora, Inc.
USD 292.87
COR
-1.51
-0.51%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.18
600276.SS
+0.14
1.80%
Lonza Group AG
USD 710.43
LONN.SW
+2.77
0.39%
Takeda Pharmaceutical Company Limited
USD 29.16
4502.T
-0.53
-1.77%